Argent Trust Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Argent Trust Co’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,326	Closed	-$420K	–	709
2023 Q4	$420K	Buy	+1,326	New	+$258K	0.02%	431

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Argent Trust Co's KRTX Position: Q1 2024 in Review

Argent Trust Co sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,326 shares — an estimated $420K sold.

Argent Trust Co first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $420K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Argent Trust Co reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Argent Trust Co sold 1,326 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $420K.
Argent Trust Co first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Argent Trust Co's Karuna Therapeutics, Inc. Common Stock position peaked at $420K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Argent Trust Co's 13F filing for Q1 2024, filed 10 May 2024.